Vira Regen Competitors and Similar CompaniesClear all

CureVac's competitors and similar companies include Deciphera Pharmaceuticals.
CureVac
CureVac
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
Founding Date
Founding Date
2000
Founding Date
2003
Type
Type
Public
Type
Public
Tags
Locations
Locations
Tübingen, DE HQ
Ottignies Louvain La Neuve, BE
Wiesbaden, DE
Amsterdam, NL
Basel, CH
Boston, US
Locations
Waltham, US HQ
Lawrence, US
Employees
Employees
82517% decrease
Employees
35037% increase
Valuation ($)
Valuation ($)
648.3 m
Valuation ($)
2.2 b

Financial

Revenue (est.)
Revenue (est.)
€535.2m (FY, 2024)
Revenue (est.)
$163.4m (FY, 2023)
Cost of goods
Cost of goods
€9.7m (FY, 2024)
Cost of goods
$3.7m (FY, 2023)
Gross profit
Gross profit
€534.4m (FY, 2024)
Gross profit
$159.6m (FY, 2023)
Net income
Net income
€162.2m (FY, 2024)
Net income
($194.9m) (FY, 2023)

Operating

Patent Applications
Patent Applications
500 (Mar, 2020)
Patent Applications
49 (Aug, 2017)

Funding

Total funding raised
Total funding raised
$ 1.1b
Total funding raised
$ 714m
For sources of this data, please see the company profile

View Company Profiles

Deciphera Pharmaceuticals
HQ
Waltham, US
Employees
350↑ 37% increase

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.

View company